BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34187504)

  • 1. Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.
    Miller H; Matsuo K; Roman LD; Yessaian AA; Pham HQ; Hom M; Castaneda A; Pham A; Ragab O; Muderspach L; Ciccone M; Brunette LL
    Radiat Oncol; 2021 Jun; 16(1):123. PubMed ID: 34187504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.
    Frumovitz M; Obermair A; Coleman RL; Pareja R; Lopez A; Ribero R; Isla D; Rendon G; Bernardini MQ; Buda A; Moretti-Marquez R; Zevallos A; Vieira MA; Zhu T; Land RP; Nicklin J; Asher R; Robledo KP; Gebski V; Ramirez PT
    Lancet Oncol; 2020 Jun; 21(6):851-860. PubMed ID: 32502445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
    Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
    Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
    Melamed A; Margul DJ; Chen L; Keating NL; Del Carmen MG; Yang J; Seagle BL; Alexander A; Barber EL; Rice LW; Wright JD; Kocherginsky M; Shahabi S; Rauh-Hain JA
    N Engl J Med; 2018 Nov; 379(20):1905-1914. PubMed ID: 30379613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
    Ramirez PT; Frumovitz M; Pareja R; Lopez A; Vieira M; Ribeiro R; Buda A; Yan X; Shuzhong Y; Chetty N; Isla D; Tamura M; Zhu T; Robledo KP; Gebski V; Asher R; Behan V; Nicklin JL; Coleman RL; Obermair A
    N Engl J Med; 2018 Nov; 379(20):1895-1904. PubMed ID: 30380365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation.
    Fanfani F; Fagotti A; Gagliardi ML; Ferrandina G; Monterossi G; Gallotta V; Zannoni GF; Scambia G
    Eur J Surg Oncol; 2013 Sep; 39(9):1025-9. PubMed ID: 23827381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Vázquez-Vicente D; Boria F; Castellanos T; Gutierrez M; Chacon E; Manzour N; Minguez JA; Martin-Calvo N; Alcazar JL; Chiva L;
    Int J Gynecol Cancer; 2024 Feb; 34(2):203-208. PubMed ID: 38669163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.
    Yoshida K; Kajiyama H; Yoshihara M; Tamauchi S; Ikeda Y; Yoshikawa N; Nishino K; Niimi K; Suzuki S; Kikkawa F
    Int J Clin Oncol; 2020 Feb; 25(2):384-390. PubMed ID: 31552530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
    Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
    Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study.
    Salvo G; Ramirez PT; Leitao MM; Cibula D; Wu X; Falconer H; Persson J; Perrotta M; Mosgaard BJ; Kucukmetin A; Berlev I; Rendon G; Liu K; Vieira M; Capilna ME; Fotopoulou C; Baiocchi G; Kaidarova D; Ribeiro R; Pedra-Nobre S; Kocian R; Li X; Li J; Pálsdóttir K; Noll F; Rundle S; Ulrikh E; Hu Z; Gheorghe M; Saso S; Bolatbekova R; Tsunoda A; Pitcher B; Wu J; Urbauer D; Pareja R
    Am J Obstet Gynecol; 2022 Jan; 226(1):97.e1-97.e16. PubMed ID: 34461074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
    DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
    Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
    Uzan C; Vincens E; Balleyguier C; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
    Int J Gynecol Cancer; 2010 Apr; 20(3):379-84. PubMed ID: 20375801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
    Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
    Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
    Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL;
    Int J Gynecol Cancer; 2020 Sep; 30(9):1269-1277. PubMed ID: 32788262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
    Kim Y; Kim SI; Kim H; Lee M; Kim HS; Kim K; Chung HH; No JH; Kim YB; Kim JW; Park NH; Song YS; Lee C; Suh DH
    Gynecol Oncol; 2022 Oct; 167(1):28-36. PubMed ID: 35970602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff - a multicenter analysis.
    Kohler C; Hertel H; Herrmann J; Marnitz S; Mallmann P; Favero G; Plaikner A; Martus P; Gajda M; Schneider A
    Int J Gynecol Cancer; 2019 Jun; 29(5):845-850. PubMed ID: 31155516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.